Amgen’s US Amjevita Sales Slow While Other Growth Drivers Deliver

 
• By Jessica Merrill
  
slow start
Amjevita sales in the US got off to a slow start • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business